#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pulmonary tuberculosis Haemophilia A with anti factor VIII Chronic lymphocytic leukaemia refractory Oropharyngeal cancer recurrent Cataract Progressive multifocal leukoencephalopathy VEXAS syndrome Chronic graft versus host disease in intestine Ehlers-Danlos syndrome B precursor type acute leukaemia Acute graft versus host disease in liver Myelin oligodendrocyte glycoprotein antibody-associated disease Chondrosarcoma metastatic Inclusion body myositis Anaplastic thyroid cancer More trials…

    Learn about Rare Diseases

    Carcinoid syndrome – Treatment Lymphangioma – Trials in Disease Haemophagocytic lymphohistiocytosis – Diagnostics Synovial sarcoma recurrent – Basic Information Hereditary hypophosphataemic rickets – Trials in Disease Alagille syndrome – Basic Information Mantle cell lymphoma – Diagnostics Piriformis syndrome – Treatment Sarcoidosis – Basic Information Systemic mastocytosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    F44/10 Aspergillus Fumigatus GSK5733584 Bimatoprost Bms-986288 Indometacin Ph. Eur. H2-Receptor Antagonist SARACATINIB Dexibuprofen Farletuzumab Ecteribulin Rezafungin Acetate Masofaniten Erythromycin IBUZATRELVIR Crovalimab Aticaprant Oxybutynin VIPOGLANSTAT Brodalumab Ltx-315 More therapies…

    Learn about Your Condition

    Sarcoma Laryngeal cancer stage I Basal cell naevus syndrome Sickle cell anaemia Ichthyosis Fabry's disease Interstitial lung disease Notalgia paraesthetica Amyloidosis Lymphangioleiomyomatosis Seasonal allergy Skin papilloma Prostatitis Escherichia coli Pancreatic carcinoma stage IV Laparotomy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Glioma

  • Study of L19TNF (onfekafusp alfa) with temozolomide chemoradiotherapy for newly diagnosed glioblastoma patients

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Glioma
    Investigated Drugs:
    • Onfekafusp Alfa
    • Temozolomide
    Germany Italy

  • Study on Using [68Ga]NOTA-AE105 to Visualize and Differentiate Gliomas in Patients

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Glioma
    Investigated Drugs:
    • [68GA]GA-NOTA-AE105
    Denmark

  • Study of L19TNF and Lomustine for Patients with Recurrent or Progressive Glioblastoma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioma
    Investigated Drugs:
    • Lomustine
    • Onfekafusp Alfa
    Germany Italy

  • Study on Quality of Life and Brain Function in Patients with Diffuse Low-Grade Gliomas Treated with Temozolomide

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioma
    Investigated Drugs:
    • Temozolomide
    France

  • Study on the Safety and Effectiveness of Vorasidenib and Temozolomide for Patients with IDH1 or IDH2 Mutant Glioma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Glioma
    Investigated Drugs:
    • Vorasidenib
    • Temozolomide
    Austria France Germany Italy The Netherlands Spain

  • Study on the Safety and Effectiveness of Sirolimus for Treating High-Grade Glioma in Children

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioma
    Investigated Drugs:
    • Sirolimus
    Poland
Previous Page
1 2 3 4
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!